# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009807
Filing Date
2022-05-13
Accepted
2022-05-13 08:19:08
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | pyxs-20220331.htm iXBRL | 10-Q | 2083283
2 | EX-10.1 | pyxs-ex10_1.htm | EX-10.1 | 586835
3 | EX-31.1 | pyxs-ex31_1.htm | EX-31.1 | 19066
4 | EX-31.2 | pyxs-ex31_2.htm | EX-31.2 | 19071
5 | EX-32.1 | pyxs-ex32_1.htm | EX-32.1 | 12268
6 | EX-32.2 | pyxs-ex32_2.htm | EX-32.2 | 11596
7 | GRAPHIC | img30572168_0.jpg | GRAPHIC | 29481
| Complete submission text file | 0000950170-22-009807.txt |  | 6874516

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | pyxs-20220331_pre.xml | EX-101.PRE | 265858
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | pyxs-20220331_lab.xml | EX-101.LAB | 347213
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | pyxs-20220331_def.xml | EX-101.DEF | 153678
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | pyxs-20220331.xsd | EX-101.SCH | 37639
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | pyxs-20220331_cal.xml | EX-101.CAL | 23662
56 | EXTRACTED XBRL INSTANCE DOCUMENT | pyxs-20220331_htm.xml | XML | 809141

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40881 | Film No.: 22920340
SIC: 2834 Pharmaceutical Preparations